We report a patient with sporadic Alzheimer’s disease with onset in his twenties found to carry the de novo Pro436Gln mutation in the presenilin 1 gene (PS1). Clinical phenotype featured a posterior cortical syndrome with severe visual agnosia and mild limb spasticity with brisk reflexes. Brain MRI and FDG-PET scans revealed severe parieto-occipital atrophy/hypometabolism. Cerebrospinal fluid biomarkers showed a decrease in Aβ42 level and Aβ42/40 ratio, increased phospho-tau, and normal total tau. Amyloid PET identified a very high burden of amyloid-β neuritic plaques in the posterior cortex. Similarities between this and two previously reported cases with this variant support that this mutation has a very strong impact on the clinical phenotype and is consistently associated with spasticity.
BirdTD (2008) Genetic aspects of Alzheimer disease. Genet Med10, 231–239.
2.
BertramL, McQueenMB, MullinK, BlackerD, TanziRE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet39, 17–23.
3.
DumanchinC, BriceA, CampionD, HannequinD, MartinC, MoreauV, AgidY, MartinezM, Clerget-DarpouxF, FrebourgT (1998) De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer’s disease cases. French Alzheimer’s Disease Study Group. J Med Genet35, 672–673.
4.
PortetF, DauvilliersY, CampionD, RauxG, HauwJJ, Lyon-CaenO, CamuW, TouchonJ (2003) Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu). Neurology61, 1136–1137.
5.
GolanMP, StyczyńskaM, JóźwiakK, WaleckiJ, MaruszakA, PniewskiJ, LugiewiczR, FilipekS, ZekanowskiC, BarcikowskaM (2007) Early-onset Alzheimer’s disease with a de novo mutation in the presenilin 1 gene. Exp Neurol208, 264–268.
6.
LiYS, YangZH, ZhangY, YangJ, ShangDD, ZhangSY, WuJ, JiY, ZhaoL, ShiCH, XuYM (2019) Two novel mutations and a de novo mutation in in early-onset Alzheimer’s disease. Aging Dis10, 908–914.
7.
LouF, LuoX, LiM, RenY, HeZ (2017) Very early-onset sporadic Alzheimer’s disease with a de novo mutation in the PSEN1 gene. Neurobiol Aging53, 193.e1–193.e5.
8.
LiuJ, WangQ, JingD, GaoR, ZhangJ, CuiC, QiaoH, LiangZ, WangC, Rosa-NetoP, WuL, JiaJ, GauthierS (2019) Diagnostic approach of early-onset dementia with negative family history: Implications from two cases of early-onset Alzheimer’s disease with de novo PSEN1 mutation. J Alzheimers Dis68, 551–558.
9.
LanoiseléeHM, NicolasG, WallonD, Rovelet-LecruxA, LacourM, RousseauS, RichardAC, PasquierF, Rollin-SillaireA, MartinaudO, Quillard-MuraineM, de la SayetteV, Boutoleau-BretonniereC, Etcharry-BouyxF, ChauviréV, SarazinM, le BerI, EpelbaumS, JonveauxT, RouaudO, CeccaldiM, FélicianO, GodefroyO, FormaglioM, CroisileB, AuriacombeS, ChamardL, VincentJL, SauvéeM, Marelli-TosiC, GabelleA, OzsancakC, ParienteJ, PaquetC, HannequinD, CampionD; collaborators of the CNR-MAJ project (2017) APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLoS Med14, e1002270.
10.
TaddeiK, KwokJB, KrilJJ, HallidayGM, CreaseyH, HalluppM, FisherC, BrooksWS, ChungC, AndrewsC, MastersCL, SchofieldPR, MartinsRN (1998) Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer’s disease. Neuroreport9, 3335–3339.
